Dr. Reddy's Laboratories Limited (DRREDDY.BO)

6.349,95 +61,65 (+0,98%) Alla chiusura: 03:29PM IST

Dr. Reddy's Laboratories Limited

8-2-337, Road No. 3
Banjara Hills
Hyderabad 500034
India
91 40 4900 2900
https://www.drreddys.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 25.863

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Gunupati Venkateswara Prasad B.E.	Co-Chairman, MD & Member of Management Council	187,71M	N/D	1960
Mr. Kallam Satish Reddy B.Tech., M.S.	Chairman of the Board & Member of the Management Council	115,4M	N/D	1967
Mr. Erez Israeli M.B.A.	CEO & Member of the Management Council	N/D	N/D	1968
Mr. Parag Agarwal	CFO & Member of Management Council	N/D	N/D	1967
Mr. Deepak Sapra M.B.A.	CEO of API & Services & Member of Management Council	N/D	N/D	1975
Mr. Venkata Ramana Motupalli M.B.A.	CEO of Branded Markets - India & Emerging Countries and Member of Management Council	N/D	N/D	1969
Ms. Archana Bhaskar B.Sc., M.B.A.	EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council	N/D	N/D	1967
Mr. Sanjay Sharma B.Tech.	Executive VP, Global Head of Global Manufacturing & Member of Management Council	N/D	N/D	1968
Mr. Marc Kikuchi B.A., M.B.A.	CEO of North America Generics & Member of Management Council	N/D	N/D	1969
Mr. Patrick Aghanian B.A., M.B.A.	CEO of European Generics & Member of Management Council	N/D	N/D	1965

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Governance aziendale

L'ISS Governance QualityScore di Dr. Reddy's Laboratories Limited al 1 maggio 2024 è 4. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 4; diritti degli azionisti: 1; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.